CClinicalTrials.gg
CompletedNCT05380661Updated Apr 28, 2026

Heart Rate Variability and Anxiety During Urinary Bladder Catheterization

An interventional study of Self-catheterization and Catheterization performed by urology nurse, participant blinded to time of procedure in Spinal Cord Injuries, Urinary Bladder, Neurogenic and Anxiety State, sponsored by University of British Columbia. Completed at 1 site in Canada. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by University of British Columbia · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Non-randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This is a prospective, randomised study investigating the physical and psychological experience of intermittent catheterization in adult individuals following spinal cord injury (SCI).

Read the detailed description

Given that intermittent catheterization is the recommended method of bladder management in individuals with SCI, it is crucial that the potentially negative cardiovascular and psychological responses to this procedure are examined. Individuals will undergo self-catheterization, then two standard of care catheterization procedures performed by an experienced urology nurse, while either blinded to or aware of time of catheterization. Continuous cardiovascular monitoring will be in place throughout all three procedures. Assessment of anxiety will be administered pre- and post- each procedure.

02

Conditions studied

  • Spinal Cord Injuries
  • Urinary Bladder, Neurogenic
  • Anxiety State
  • Catheter Complications
  • Autonomic Dysreflexia

Keywords

  • Intermittent Catheterization
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 22 is close to the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Male or female, 18-70 years of age
  • Any chronic traumatic SCI with either motor sensory complete injury (AIS A/B, N=10) or motor sensory incomplete injury (AIS B/D, N=10).
  • At least 1 year post injury, and at least 6 months from any spinal surgery
  • Hand function sufficient to perform intermittent catheterization for management of urinary bladder drainage
  • Must provide informed consent and be able to understand and complete study-related questionnaires (must be able to understand and speak English or have access to an appropriate interpreter as judged by the investigator)
  • Willing and able to comply with clinic visit and study-related procedures

Exclusion criteria

Exclusion Criteria:

  • Signs or known current urinary tract infection, or other inflammatory conditions of bladder/urethra
  • Currently taking beta blockers or other medications that may affect heart rate
  • History of ureteral injury
  • History of any urinary diversion procedures, including but not limited to bladder augmentation, cystectomy, neo bladder, pouch reservoir, ileal conduit, Mitrofanoff appendicovesicostomy
  • For women of childbearing potential, currently pregnant
  • A member of the investigational team or his/her immediate family Presence of severe acute medical issue and use of any specific medication or treatment that, in the investigator's judgement, would adversely affect the participant's participation in the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Single group
Masking
Single (Participant)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Individuals with motor-complete SCI

    Individuals with motor sensory complete injury (AIS A/B)

    Procedure: Self-catheterization · Procedure: Catheterization performed by urology nurse, participant blinded to time of procedure · Procedure: Catheterization performed by urology nurse, participant aware of time of procedure

  • Experimental
    Individuals with motor-incomplete SCI

    Individuals with motor sensory incomplete injury (AIS C/D)

    Procedure: Self-catheterization · Procedure: Catheterization performed by urology nurse, participant blinded to time of procedure · Procedure: Catheterization performed by urology nurse, participant aware of time of procedure

Interventions

  • ProcedureSelf-catheterization

    Participants will perform self-catheterization, following the same routine for intermittent catheterization at home

  • ProcedureCatheterization performed by urology nurse, participant blinded to time of procedure

    Participant will undergo procedure to completely empty bladder; Participant in supine position, and resting blood pressure and heart rate will be recorded for period of 5 minutes prior to catheterization; Perineum and genital areas will be draped and they will be not aware about exact timing of catheterization Catheterization will be conducted following standard clinic procedure by experience urology nurse.

  • ProcedureCatheterization performed by urology nurse, participant aware of time of procedure

    Participant will undergo procedure to completely empty bladder; Participant in supine position, and resting BP and HR will be recorded for period of 5 minutes prior to catheterization; Perineum and genital areas will be visible to participant and they will be fully aware about exact timing of catheterization Catheterization will be conducted following standard clinic procedure by experience urology nurse.

06

What researchers measure

Primary outcomes

  1. Blood pressure (BP) during self-catheterization

    Systolic and diastolic BP (mmHg) will be measured continuously (beat-by-beat) via finger photoplethysmography, corrected to brachial pressure. BP will be measured 5 minutes prior to and then throughout the self-catheterization procedure.

    Time frame: During self-catheterization

  2. Heart rate (HR) during self-catheterization

    HR (BPM) will be recorded continuously via one-lead electrocardiogram. HR will be measured 5 minutes prior to and then throughout the self-catheterization procedure.

    Time frame: During self-catheterization

  3. BP during catheterization performed by urology nurse, participant blinded to time of procedure

    Systolic and diastolic BP (mmHg) will be measured 5 minutes prior to and then throughout the standard of care catheterization performed by an experienced urology nurse, while the participant is blinded to time of procedure.

    Time frame: During catheterization performed by urology nurse, participant blinded to time of procedure

  4. HR during catheterization performed by urology nurse, participant blinded to time of procedure

    HR (BPM) will be measured 5 minutes prior to and then throughout the standard of care catheterization performed by an experienced urology nurse, while the participant is blinded to time of procedure.

    Time frame: During catheterization performed by urology nurse, participant blinded to time of procedure

  5. BP during catheterization performed by urology nurse, participant aware of time of procedure

    Systolic and diastolic BP (mmHg) will be measured 5 minutes prior to and then throughout the standard of care catheterization performed by an experienced urology nurse, while the participant is aware of time of procedure.

    Time frame: During catheterization performed by urology nurse, participant aware of time of procedure

  6. HR during catheterization performed by urology nurse, participant aware of time of procedure

    HR (BPM) will be measured 5 minutes prior to and then throughout the standard of care catheterization performed by an experienced urology nurse, while the participant is aware of time of procedure.

    Time frame: During catheterization performed by urology nurse, participant aware of time of procedure

  7. Change in state anxiety in the context of self-catheterization (STAIS-5)

    The State-Trait Anxiety Inventory - State, 5 item version (STAIS-5) will be used to measure participants' state anxiety prior to and after self-catheterization. Sum score of the STAIS-5 will be calculated, which ranges between 5 to 20, with higher score indicating greater state anxiety.

    Time frame: 5 minutes before and 5 minutes after self-catheterization

  8. Change in state anxiety in the context of catheterization performed by urology nurse, participant blinded to time of procedure (STAIS-5)

    The STAIS-5 will be used to measure participants' state anxiety prior to and after catheterization procedure performed by an experienced urology nurse, while the participant is blinded to time of procedure. Sum score of the STAIS-5 will be calculated, which ranges between 5 to 20, with higher score indicating greater state anxiety.

    Time frame: 5 minutes before and 5 minutes after catheterization performed by urology nurse, participant blinded to time of procedure

  9. Change in state anxiety in the context of catheterization performed by urology nurse, participant aware of time of procedure (STAIS-5)

    The STAIS-5 will be used to measure participants' state anxiety prior to and after catheterization procedure performed by an experienced urology nurse, while the participant is aware of time of procedure. Sum score of the STAIS-5 will be calculated, which ranges between 5 to 20, with higher score indicating greater state anxiety.

    Time frame: 5 minutes before and 5 minutes after catheterization performed by urology nurse, participant aware of time of procedure

Secondary outcomes

  1. Baseline trait anxiety

    The 7-item General Anxiety Disorder (GAD) scale will be used to measure participants' anxiety. The GAD-7 sum score will be calculated, ranging from 0 to 21, with higher score indicating more severe anxiety symptoms.

    Time frame: During screening

  2. Change in state anxiety in the context of self-catheterization (GA-VAS)

    The Global Anxiety-Visual Analogue Scale (GA-VAS) will be used to measure participants' state anxiety prior to and after self-catheterization. Rating can range between 0 to 10, with higher rating on the GA-VAS indicates greater state anxiety.

    Time frame: 5 minutes before and 5 minutes after self-catheterization

  3. Change in state anxiety in the context of catheterization performed by urology nurse, participant blinded to time of procedure (GA-VAS)

    The GA-VAS will be used to measure participants' state anxiety prior to and after catheterization procedure performed by an experienced urology nurse, while the participant is blinded to time of procedure. Rating can range between 0 to 10, higher rating on the GA-VAS indicates greater state anxiety.

    Time frame: 5 minutes before and 5 minutes after catheterization performed by urology nurse, participant blinded to time of procedure

  4. Change in state anxiety in the context of catheterization performed by urology nurse, participant aware of time of procedure (GA-VAS)

    The GA-VAS will be used to measure participants' state anxiety prior to and after catheterization procedure performed by an experienced urology nurse, while the participant is aware of time of procedure. Higher rating on the GA-VAS indicates greater state anxiety.

    Time frame: 5 minutes before and 5 minutes after catheterization performed by urology nurse, participant aware of time of procedure

  5. Change in heart rate variability (HRV) during self-catheterization

    HRV will be calculated from continuous ECG recording

    Time frame: During self-catheterization

  6. Change in heart rate variability (HRV) during catheterization performed by urology nurse, participant blinded to time of procedure

    HRV will be calculated from continuous ECG recording

    Time frame: During catheterization performed by urology nurse, participant blinded to time of procedure

  7. Change in heart rate variability (HRV) during catheterization performed by urology nurse, participant aware of time of procedure

    HRV will be calculated from continuous ECG recording

    Time frame: During catheterization performed by urology nurse, participant aware of time of procedure

07

Study locations

1 site
  • Blusson Spinal Cord Centre
    Vancouver, British Columbia V5Z 1M9, Canada
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05380661
Lead sponsor
University of British Columbia
Collaborators
ConvaTec Inc., Vancouver Coastal Health, International Collaboration on Repair Discoveries
Responsible party
Andrei Krassioukov (Principal Investigator, University of British Columbia) — Principal investigator
First posted
May 19, 2022
Start date
Jul 15, 2022
Primary completion
Apr 16, 2026
Completion
Apr 16, 2026
Last update
Apr 28, 2026

Study contacts

Andrei Krassioukov, MD,PhD,FRCPC
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion